Landmark Bio will serve as strategic point-of-care manufacturing partner for Galapagos’ CAR-T product candidates in the Boston area
Landmark Bio will serve as strategic partner in the development and manufacturing of InnDura’s pipeline products
New 44,000 square-foot fully integrated facility for development, manufacturing and testing of cell and gene therapies in Watertown, Massachusetts, offers end-to-end capabilities and onestop manufacturing solutions
Newest members of Landmark Bio’s executive team bring decades of industry leadership and expertise in drug development and biomanufacturing
Zheng will lead the construction of the new, state-of-the-art biomanufacturing facility that kicks off today (July 29) in Watertown, MA and will begin opening in 2022.